The VPH Institute together with the Avicenna Alliance, the Insigneo Institute for in silico Medicine and the Alma Mater Studiorum, University of Bologna has drafted an open letter, which will be sent to Prof Guido Rasi – the Director of EMA to raise our collective voices to promote the adoption of In Silico Trials through EMA’s strategy.Read More
The Insigneo Institute for in silico Medicine seeks to achieve scientific ambition behind the Virtual Physiological Human (VPH), producing a transformational impact on healthcare.
Insigneo brings together highly respected researchers and clinicians from across the University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust. Members collaborate across disciplines and with international partners in industry, academia and healthcare. This enables Insigneo to define and address, with the wider VPH community, clinical and technological challenges inherent in in silico medicine.